NCT03103646View on ClinicalTrials.gov

Study Evaluating the Effect of Multiple Doses of Itraconazole on the Drug Lu AF35700 in Healthy Young Men and Women

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 28, 2017

Primary Completion Date

April 14, 2019

Study Completion Date

July 19, 2019

Conditions
Cytochrome P450 Interaction
Interventions
DRUG

Lu AF35700

Tablets for oral use, single dose in a fasted state. EMs: 10 mg/day, PMs: 5 mg

DRUG

Itraconazole (200 mg)

100 mg Capsules for oral use, 200 mg/day. In a fed state

DRUG

Itraconazole (300 mg)

100mg Capsules for oral use, 300 mg/day. In a fasted state.

Trial Locations (2)

75247

Covance - Dallas, Dallas

Unknown

Covance Clinical Research Unit Ltd, Leeds

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT03103646 - Study Evaluating the Effect of Multiple Doses of Itraconazole on the Drug Lu AF35700 in Healthy Young Men and Women | Biotech Hunter | Biotech Hunter